I manage the global patent portfolios of a number of ASX and NASDAQ listed biotechnology companies and have extensive experience running patent oppositions before the Australian and New Zealand Patent Offices. I have also been involved in a number of high-profile patent litigation matters in Australia.

Career highlights

I have a Ph.D in the fields of organic chemistry and photochemistry. My doctoral research involved the synthesis of complex organic molecules for studying electron and energy transfer processes. I am the co-author of more than 10 publications in peer reviewed journals, including the Journal of the American Chemical Society.

• Securing patents for an Australian university that were subsequently licensed and earned substantial royalties for the university
• Developing and executing a successful global patent strategy to protect a key compound for a listed Australian biotechnology company in the face of a difficult prior art landscape
• Acting for Bayer CropScience AG and Allergan Inc. in a number of significant Australian patent oppositions
• Providing technical advice to Bayer Pharma AG in the Australian Yasmin litigation relating to oral contraceptives
• Providing ownership and inventorship opinions to a range of Australian universities

Awards & recognition

• Leading patent professional in Intellectual Asset Management 1000 (IAM 1000) 2018, 2019, 2020 and 2021
• Leading lawyer for Life Sciences – Australia in Expert Guides, 2018 (one of eight listed).